Skip to main content
. 2014 Sep 22;9(9):e107193. doi: 10.1371/journal.pone.0107193

Figure 3. Heterogeneity analysis by patient and in time.

Figure 3

(A) Patient heterogeneity implies four prognosis clusterse driven by different LRPs. (B) Each of these clusters has a distinct prognosis. (C) Over time, there are significant changes in the prognostic association and specific LRPs at about 9 and 27 months, close to the second treatment times for platinum resistant and sensitive patients.